Mujahed I. Mustafa* and Abdelrafie M. Makhawi
DOI: 10.37421/2576-1420.2023.8.274
The recent COVID-19 outbreak demonstrated how ineffectively may face newly emerging viruses. Antiviral drugs are the most effective way to combat the COVID-19 pandemic. However, their rapidly declining immunity and a large population of unvaccinated people will provide a recombinant ground for the virus's spread and the era of novel variants, posing a continuous threat of infection for vulnerable groups with inadequate immune responses. In order to treat infected people, effective treatments must be developed. In this short note, discuss a breakthrough in engineered antibody fragment that could be neutralized the shield against the battle of the continuous waves of SARS-CoV-2 variants as well as future other viral infections.
Eifler Vagner
Avalos Andrii
Hensel Stepan
Talik Evgeny
Journal of Infectious Diseases and Medicine received 1059 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 